To determine whether the expression profiles of Oct4, M-CSF, and CD206 in lung cancer have clinical relevance, we examined their expression and correlation in clinical specimens of 22 patients with stages IB, IIB, and IIIA lung cancers. The gene discussed is CSF1; the disease is lung carcinoma.